CONMED Corp Annual Deferred Income Tax Expense (Benefit) in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
CONMED Corp annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
  • CONMED Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $1.87M.
  • CONMED Corp annual Deferred Income Tax Expense (Benefit) for 2024 was $12.2M, a 1643% increase from 2023.
  • CONMED Corp annual Deferred Income Tax Expense (Benefit) for 2023 was $700K.
  • CONMED Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$6.04M, a 301% decline from 2021.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.